| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.100 | None | 0.979 | 329 | 4 | 1990 | 2020 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
group | 0.100 | None | 0.984 | 322 | 0 | 2006 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.944 | 304 | 9 | 1980 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.977 | 299 | 8 | 1992 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
group | 0.100 | None | 0.933 | 282 | 1 | 1990 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.984 | 253 | 5 | 2003 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
group | 0.100 | None | 0.988 | 253 | 0 | 2004 | 2020 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.400 | None | 0.959 | 246 | 13 | 1995 | 2020 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.100 | None | 0.979 | 243 | 0 | 2007 | 2020 | |||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.100 | None | 0.948 | 229 | 17 | 1985 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 227 | 7 | 1995 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 0.978 | 227 | 2 | 1989 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
group | 0.100 | None | 0.973 | 224 | 0 | 2000 | 2020 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.100 | None | 0.968 | 222 | 7 | 1989 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.100 | None | 0.982 | 218 | 4 | 1995 | 2020 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
group | 0.100 | None | 0.991 | 211 | 2 | 1997 | 2020 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
group | 0.100 | None | 0.995 | 211 | 6 | 1998 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.966 | 207 | 2 | 1991 | 2020 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
group | 0.400 | None | 0.966 | 207 | 10 | 1999 | 2020 | ||||||||
|
heat shock protein 90 alpha family class A member 1 | 0.411 | 0.923 | 0.86 |
|
group | 0.100 | None | 0.970 | 202 | 0 | 2004 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.100 | None | 0.985 | 200 | 2 | 1994 | 2020 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
group | 0.100 | None | 0.970 | 197 | 6 | 2005 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.100 | None | 0.974 | 190 | 1 | 1988 | 2020 | ||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
group | 0.100 | None | 0.968 | 190 | 6 | 2012 | 2020 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.984 | 184 | 0 | 2004 | 2020 |